Park Avenue Securities LLC Sells 1,264 Shares of Omega Healthcare Investors, Inc. $OHI

Park Avenue Securities LLC lessened its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 6.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,270 shares of the real estate investment trust’s stock after selling 1,264 shares during the period. Park Avenue Securities LLC’s holdings in Omega Healthcare Investors were worth $633,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in OHI. AQR Capital Management LLC raised its holdings in shares of Omega Healthcare Investors by 430.8% in the first quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust’s stock valued at $108,989,000 after purchasing an additional 2,322,878 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Omega Healthcare Investors by 3.9% in the first quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust’s stock valued at $1,506,250,000 after purchasing an additional 1,492,904 shares during the last quarter. Invesco Ltd. raised its holdings in shares of Omega Healthcare Investors by 122.3% in the first quarter. Invesco Ltd. now owns 2,416,560 shares of the real estate investment trust’s stock valued at $92,023,000 after purchasing an additional 1,329,324 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Omega Healthcare Investors in the first quarter valued at approximately $42,513,000. Finally, Allspring Global Investments Holdings LLC raised its holdings in shares of Omega Healthcare Investors by 556.1% in the first quarter. Allspring Global Investments Holdings LLC now owns 1,028,187 shares of the real estate investment trust’s stock valued at $39,143,000 after purchasing an additional 871,472 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Price Performance

NYSE:OHI opened at $41.80 on Monday. Omega Healthcare Investors, Inc. has a one year low of $35.04 and a one year high of $44.42. The company has a market cap of $12.33 billion, a P/E ratio of 25.80, a P/E/G ratio of 2.19 and a beta of 0.71. The firm’s fifty day moving average price is $41.12 and its two-hundred day moving average price is $38.58. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm had revenue of $235.60 million for the quarter, compared to the consensus estimate of $248.49 million. During the same period in the previous year, the company earned $0.71 earnings per share. The company’s quarterly revenue was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Equities analysts expect that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 6.4%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors’s payout ratio is currently 165.43%.

Insider Activity at Omega Healthcare Investors

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the transaction, the director directly owned 18,654 shares in the company, valued at approximately $749,144.64. This represents a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

OHI has been the topic of a number of recent research reports. Scotiabank lifted their price objective on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a report on Thursday, August 28th. Truist Financial lifted their price objective on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a “hold” rating in a report on Wednesday, September 3rd. Mizuho boosted their target price on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a report on Thursday, September 11th. Wells Fargo & Company boosted their target price on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an “overweight” rating in a report on Wednesday, August 27th. Finally, Royal Bank Of Canada boosted their target price on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a “sector perform” rating in a report on Thursday, August 7th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $43.75.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.